Back to Newsroom
Back to Newsroom

Five Star Equities Issues New Research Reports on GM, IPI, MDRX and PETM

Thursday, 16 January 2014 09:00 AM

Topic:

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.

General Motors Company (NYSE: GM) shares declined 1.60 percent to close at $39.38 a share Wednesday. The stock traded between $38.96 and $39.77 on volume 89.21 million shares traded. The company announced that it expects profit to rise in 2014 due to new vehicle launches. Shares of General Motors have gained approximately 30.0 percent in the past year.

Get more information on General Motors and free access to the in-depth equity report at:  
www.FiveStarEquities.com/GM

Intrepid Potash, Inc. (NYSE: IPI) shares increased 1.28 percent to close at $16.63 a share Wednesday. The stock traded between $16.47 and $17.29 on volume of 1.57 million shares traded. The company announced a number of cost-savings initiatives include the elimination of approximately 7% of the workforce. Shares of Intrepid Potash have fallen approximately 25.0 percent in the past year.

Get more information on Intrepid Potash and free access to the in-depth equity report at:  
www.FiveStarEquities.com/IPI

Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) shares spiked 7.67 percent to close at $16.71 a share Wednesday. The stock traded between $15.90 and $16.98 on volume 4.86 million shares traded. According to a recent regulatory filing, the company expects revenues to increase in the range of 5.0 percent to 8.0 percent each year from 2014 through 2016. Shares of Allscripts Healthcare Solutions have gained approximately 65.0 percent in the past year.

Get more information on Allscripts and free access to the in-depth equity report at:  
www.FiveStarEquities.com/MDRX

PetSmart, Inc. (NASDAQ: PETM) shares declined 2.41 percent to close at $65.48 a share Wednesday. The stock traded between $65.00 and $66.25 on volume 3.81 million shares traded. Analysts at both Credit Suisse and UBS have recently downgraded the company's rating to neutral and have also lowered its price target on the stock. Shares of PetSmart have fallen approximately 4.0 percent in the past year.

Get more information on PetSmart free access to the in-depth equity report at:  
www.FiveStarEquities.com/PETM

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:         
Five Star Equities
[email protected]

Topic:
Back to newsroom
Back to Newsroom
Share by: